AHG
Akso Health Group
Price Chart
Latest Quote
$1.47
Current Price| Previous Close | $1.42 |
| Open | $1.46 |
| Day High | $1.50 |
| Day Low | $1.45 |
| Volume | 3,113 |
Stock Information
| Shares Outstanding | 549.20M |
| Total Debt | $2.08M |
| Cash Equivalents | $176.23M |
| Revenue | $14.78M |
| Net Income | $-134.98M |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Market Cap | $807.33M |
| EPS (TTM) | $-0.48 |
| Exchange | NCM |
đ Custom Metrics & Score
Score: 19/42| Debt to Equity | 0.00 |
| Debt to Earnings | -0.29 |
| Current Ratio | 14.20 |
| Quick Ratio | 13.69 |
| Avg Revenue Growth | 36.57% |
| Profit Margin | -913.38% |
| Return on Equity | -67.79% |
| Avg FCF Growth | -27.96% |
| FCF Yield | 0.13% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $1.47 | 3,100 |
| 2026-01-30 | $1.42 | 4,500 |
| 2026-01-29 | $1.39 | 12,400 |
| 2026-01-28 | $1.42 | 4,300 |
| 2026-01-27 | $1.43 | 1,900 |
| 2026-01-26 | $1.41 | 1,200 |
| 2026-01-23 | $1.51 | 4,300 |
| 2026-01-22 | $1.52 | 5,300 |
| 2026-01-21 | $1.57 | 24,700 |
| 2026-01-20 | $1.52 | 7,600 |
| 2026-01-16 | $1.59 | 9,900 |
| 2026-01-15 | $1.53 | 21,800 |
| 2026-01-14 | $1.41 | 31,800 |
| 2026-01-13 | $1.45 | 16,700 |
| 2026-01-12 | $1.54 | 29,200 |
| 2026-01-09 | $1.38 | 700 |
| 2026-01-08 | $1.33 | 2,000 |
| 2026-01-07 | $1.38 | 41,500 |
| 2026-01-06 | $1.35 | 4,400 |
| 2026-01-05 | $1.49 | 17,500 |
About Akso Health Group
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
đ° Latest News
While Akso Health Group (NASDAQ:AHG) shareholders have made 235% in 3 years, increasing losses might now be front of mind as stock sheds 10% this week
Simply Wall St. âĸ 2025-11-15T12:40:25Z
Why Akso Health Group (AHG) Faces Uncertainty After Auditor Flags Doubt on Financial Viability
Simply Wall St. âĸ 2025-08-22T10:08:00Z
Akso Health Group (NASDAQ:AHG) investors are sitting on a loss of 27% if they invested three years ago
Simply Wall St. âĸ 2025-03-31T12:11:12Z
Income Statement (Annual)
Revenue
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $15,059,324 | $2,292,206 | $11,912,571 | $5,394,866 |
| Cost Of Revenue | $15,059,324 | $2,292,206 | $11,912,571 | $5,394,866 |
| Total Revenue | $14,777,798 | $2,414,338 | $13,181,561 | $6,000,000 |
| Operating Revenue | $14,781,622 | $2,416,797 | $13,186,525 | $6,000,000 |
Expenses
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Expenses | $18,700,770 | $11,052,378 | $27,448,414 | $8,456,325 |
| Other Income Expense | $-162,347,307 | $-453,751 | $1,200,364 | $-747,818 |
| Other Non Operating Income Expenses | $34,099 | $138,240 | $57,358 | $684 |
| Operating Expense | $3,641,446 | $8,760,172 | $15,535,843 | $3,061,459 |
| Selling And Marketing Expense | $0 | $168,421 | $6,661 | $0 |
| General And Administrative Expense | $3,641,446 | $8,591,751 | $15,529,182 | $3,061,459 |
| Interest Expense | - | $0 | $0 | $804,138 |
| Net Non Operating Interest Income Expense | - | $0 | $0 | $-804,138 |
| Interest Expense Non Operating | - | $0 | $0 | $804,138 |
Income & Earnings
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-134,977,369 | $-9,058,986 | $-13,196,535 | $-4,102,428 |
| Normalized Income | $-2,676,705 | $-8,614,993 | $-14,053,790 | $-3,541,052 |
| Net Income From Continuing And Discontinued Operation | $-134,977,369 | $-9,458,784 | $-1,359,923 | $-16,851,064 |
| Total Operating Income As Reported | $-166,304,352 | $-8,638,040 | $-14,266,853 | $-3,260,463 |
| Net Income Common Stockholders | $-134,977,369 | $-9,458,784 | $-1,359,923 | $-16,851,064 |
| Net Income | $-134,977,369 | $-9,458,784 | $-1,359,923 | $-16,851,064 |
| Net Income Including Noncontrolling Interests | $-135,469,133 | $-9,516,577 | $-1,247,426 | $-16,849,733 |
| Net Income Discontinuous Operations | $0 | $-399,798 | $11,836,612 | $-12,748,636 |
| Net Income Continuous Operations | $-135,469,133 | $-9,116,779 | $-13,084,038 | $-4,101,097 |
| Pretax Income | $-166,270,279 | $-9,091,791 | $-13,066,489 | $-4,008,281 |
| Special Income Charges | $-162,381,380 | $0 | $0 | $0 |
| Operating Income | $-3,922,972 | $-8,638,040 | $-14,266,853 | $-2,456,325 |
| Gross Profit | $-281,526 | $122,132 | $1,268,990 | $605,134 |
| Net Interest Income | - | $0 | $0 | $-804,138 |
Per Share Metrics
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Diluted EPS | $-0.48 | $-0.21 | $-0.06 | $-0.84 |
| Basic EPS | $-0.48 | $-0.21 | $-0.06 | $-0.84 |
Other
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $-30,080,742 | $-147,998 | $285,752 | $-187,126 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $160,608,224 | $-8,046,049 | $-15,409,859 | $-2,455,641 |
| Total Unusual Items | $-162,381,406 | $-591,991 | $1,143,006 | $-748,502 |
| Total Unusual Items Excluding Goodwill | $-162,381,406 | $-591,991 | $1,143,006 | $-748,502 |
| Reconciled Depreciation | $2,149,790 | $0 | $0 | $18,390 |
| EBITDA (Bullshit earnings) | $-1,773,182 | $-8,638,040 | $-14,266,853 | $-3,204,143 |
| EBIT | $-3,922,972 | $-8,638,040 | $-14,266,853 | $-3,204,143 |
| Diluted Average Shares | $285,096,112 | $47,172,259 | $22,866,017 | $19,870,717 |
| Basic Average Shares | $285,096,112 | $47,172,259 | $22,866,017 | $19,870,717 |
| Diluted NI Availto Com Stockholders | $-134,977,369 | $-9,458,784 | $-1,359,923 | $-16,851,064 |
| Minority Interests | $491,764 | $57,793 | $-112,497 | $-1,331 |
| Tax Provision | $-30,801,146 | $24,988 | $17,549 | $92,816 |
| Impairment Of Capital Assets | $162,381,380 | $0 | $0 | - |
| Gain On Sale Of Security | $-26 | $-591,991 | $1,143,006 | $-748,502 |
| Selling General And Administration | $3,641,446 | $8,760,172 | $15,535,843 | $3,061,459 |
| Other Gand A | $3,641,446 | $8,591,751 | $15,529,182 | $2,669,834 |
| Excise Taxes | $3,824 | $2,459 | $4,964 | $0 |
| Salaries And Wages | - | $0 | $0 | $391,625 |
| Write Off | - | - | - | $0 |
| Research And Development | - | - | - | $421,186 |
Balance Sheet (Annual)
Assets
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Net Tangible Assets | $180,405,256 | $138,367,384 | $8,725,304 | $12,283,606 |
| Total Assets | $214,953,325 | $142,018,117 | $20,460,299 | $62,806,508 |
| Total Non Current Assets | $18,828,433 | $0 | $0 | $176,977 |
| Goodwill And Other Intangible Assets | $18,713,889 | $0 | - | - |
| Other Intangible Assets | $7,880,154 | - | - | - |
| Current Assets | $196,124,892 | $142,018,117 | $20,460,299 | $62,629,531 |
| Other Current Assets | $6,809,198 | $402,899 | $272,129 | - |
| Prepaid Assets | $0 | $56,250,000 | $0 | $176,978 |
| Inventory | $190,242 | $191,201 | $1,686,449 | $7,795,822 |
| Receivables | $12,895,578 | $0 | $9,225,901 | $20,000,000 |
| Loans Receivable | $11,941,378 | $0 | - | $0 |
| Accounts Receivable | $954,200 | $0 | $7,696,983 | $0 |
| Allowance For Doubtful Accounts Receivable | $-7,670,556 | $-7,770,556 | $-400,759 | $0 |
| Gross Accounts Receivable | $8,624,756 | $7,770,556 | $8,097,742 | $0 |
| Cash Cash Equivalents And Short Term Investments | $176,229,874 | $85,174,017 | $7,924,468 | $18,429,987 |
| Cash And Cash Equivalents | $176,229,874 | $85,174,017 | $7,924,468 | $18,429,987 |
| Assets Held For Sale Current | - | $0 | $1,351,352 | $16,403,722 |
| Other Non Current Assets | - | - | $272,129 | $176,977 |
| Other Receivables | - | - | $1,528,918 | $20,000,000 |
| Accrued Interest Receivable | - | - | - | $2,055 |
| Non Current Note Receivables | - | - | - | - |
| Non Current Accounts Receivable | - | - | - | - |
Debt
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Debt | $81,737 | $0 | - | - |
| Long Term Debt And Capital Lease Obligation | $41,679 | $0 | - | - |
| Current Debt And Capital Lease Obligation | $40,058 | - | - | - |
| Current Debt | - | - | - | - |
| Other Current Borrowings | - | - | - | - |
Liabilities
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $15,802,189 | $3,593,923 | $11,620,783 | $50,520,926 |
| Total Non Current Liabilities Net Minority Interest | $1,989,282 | $0 | $0 | $0 |
| Non Current Deferred Liabilities | $1,947,603 | $0 | - | - |
| Non Current Deferred Taxes Liabilities | $1,947,603 | $0 | - | - |
| Current Liabilities | $13,812,907 | $3,593,923 | $11,620,783 | $50,520,926 |
| Current Deferred Liabilities | $10,217,048 | $415,020 | $194,376 | $0 |
| Payables And Accrued Expenses | $3,555,801 | $3,178,903 | $10,720,924 | $37,518,697 |
| Interest Payable | $0 | $9,450 | $105,085 | $127,244 |
| Payables | $2,033,863 | $2,074,091 | $9,782,157 | $37,292,816 |
| Total Tax Payable | $33,863 | $74,091 | $96,005 | $92,816 |
| Income Tax Payable | $92,816 | $92,816 | $95,888 | $92,816 |
| Other Current Liabilities | - | - | $705,483 | $13,002,229 |
| Current Notes Payable | - | - | - | $0 |
Equity
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Common Stock Equity | $199,119,145 | $138,367,384 | $8,725,304 | $12,283,606 |
| Total Equity Gross Minority Interest | $199,151,136 | $138,424,194 | $8,839,516 | $12,285,582 |
| Stockholders Equity | $199,119,145 | $138,367,384 | $8,725,304 | $12,283,606 |
| Gains Losses Not Affecting Retained Earnings | $-3,771,374 | $-4,086,587 | $-3,847,601 | $-1,649,223 |
| Other Equity Adjustments | $-3,771,374 | $-4,086,587 | $-3,847,601 | $-1,649,223 |
| Retained Earnings | $-198,903,752 | $-63,926,383 | $-54,467,600 | $-53,107,676 |
Other
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Treasury Shares Number | $1,165,883 | $1,165,883 | $1,165,883 | $1,165,883 |
| Ordinary Shares Number | $1,647,602,730 | $437,170,960 | $68,598,050 | $68,598,050 |
| Share Issued | $1,648,768,613 | $438,336,843 | $69,763,933 | $69,763,933 |
| Tangible Book Value | $180,405,256 | $138,367,384 | $8,725,304 | $12,283,606 |
| Invested Capital | $199,119,145 | $138,367,384 | $8,725,304 | $12,283,606 |
| Working Capital | $182,311,985 | $138,424,194 | $8,839,516 | $12,108,605 |
| Capital Lease Obligations | $81,737 | $0 | - | - |
| Total Capitalization | $199,119,145 | $138,367,384 | $8,725,304 | $12,283,606 |
| Minority Interest | $31,991 | $56,810 | $114,212 | $1,976 |
| Treasury Stock | $3,988,370 | $3,988,370 | $3,988,370 | $3,988,370 |
| Additional Paid In Capital | $405,616,966 | $210,324,890 | $71,021,898 | $71,021,898 |
| Capital Stock | $165,675 | $43,834 | $6,977 | $6,977 |
| Common Stock | $165,675 | $43,834 | $6,977 | $6,977 |
| Long Term Capital Lease Obligation | $41,679 | $0 | - | - |
| Current Deferred Revenue | $10,217,048 | $415,020 | $194,376 | $0 |
| Current Capital Lease Obligation | $40,058 | $0 | - | - |
| Current Accrued Expenses | $1,521,938 | $1,104,812 | $938,767 | $225,881 |
| Dueto Related Parties Current | $2,000,000 | $2,000,000 | $9,686,152 | $37,200,000 |
| Goodwill | $10,833,735 | $0 | - | - |
| Net PPE | $114,544 | $0 | - | $55,433 |
| Accumulated Depreciation | $-1,612 | - | - | $-85,880 |
| Gross PPE | $116,156 | $0 | - | $141,313 |
| Other Properties | $98,396 | - | - | - |
| Machinery Furniture Equipment | $17,760 | - | - | $141,313 |
| Finished Goods | $190,242 | $191,201 | $1,686,449 | $7,795,822 |
| Investments And Advances | - | - | - | - |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Free Cash Flow | $1,022,703 | $1,351,240 | $-3,253,340 | $-8,628,371 |
Operating Activities
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Operating Cash Flow | $1,177,163 | $1,351,240 | $-3,253,340 | $-8,628,371 |
| Cash From Discontinued Operating Activities | $0 | $645,869 | $2,729,242 | $2,652,097 |
| Cash Flow From Continuing Operating Activities | $1,177,163 | $705,371 | $-5,982,582 | $-11,280,468 |
| Operating Gains Losses | - | - | - | - |
Investing Activities
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Capital Expenditure | $-154,460 | - | - | $-4,861 |
| Investing Cash Flow | $-105,912,692 | $-54,721,082 | $18,471,082 | $-19,963,860 |
| Cash From Discontinued Investing Activities | $0 | $0 | $0 | $36,140 |
| Cash Flow From Continuing Investing Activities | $-105,912,692 | $-54,721,082 | $18,471,082 | $-20,000,000 |
| Net Other Investing Changes | $-12,008,232 | $1,528,918 | $18,471,082 | $-20,000,000 |
Financing Activities
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Issuance Of Capital Stock | $195,884,024 | $139,339,849 | $0 | $10,017,200 |
| Financing Cash Flow | $195,884,024 | $131,653,697 | $-27,513,848 | $34,781,117 |
| Cash From Discontinued Financing Activities | $0 | $0 | $0 | $25,677,113 |
| Cash Flow From Continuing Financing Activities | $195,884,024 | $131,653,697 | $-27,513,848 | $9,104,004 |
| Net Common Stock Issuance | $195,884,024 | $139,339,849 | $0 | $10,017,200 |
| Common Stock Issuance | $195,884,024 | $139,339,849 | $0 | $10,017,200 |
| Repurchase Of Capital Stock | - | - | - | $0 |
| Net Other Financing Charges | - | - | - | $9,086,804 |
| Cash Dividends Paid | - | - | - | - |
Other
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Repayment Of Debt | $0 | $-7,686,152 | $-27,513,848 | $-10,000,000 |
| Interest Paid Supplemental Data | $0 | $111,563 | $336,593 | $676,894 |
| Income Tax Paid Supplemental Data | $2,982 | $24,988 | $17,549 | $92,816 |
| End Cash Position | $176,229,874 | $86,204,394 | $9,192,703 | $21,925,322 |
| Beginning Cash Position | $86,204,394 | $9,192,703 | $21,925,322 | $15,128,719 |
| Effect Of Exchange Rate Changes | $-1,123,015 | $-1,272,164 | $-436,513 | $607,717 |
| Changes In Cash | $91,148,495 | $78,283,855 | $-12,296,106 | $6,188,886 |
| Net Issuance Payments Of Debt | $0 | $-7,686,152 | $-27,513,848 | $-10,000,000 |
| Net Short Term Debt Issuance | $0 | $-7,686,152 | $-27,513,848 | $-10,000,000 |
| Short Term Debt Payments | $0 | $-7,686,152 | $-27,513,848 | $-10,000,000 |
| Net Business Purchase And Sale | $-93,750,000 | $-56,250,000 | $0 | - |
| Purchase Of Business | $-93,750,000 | $-56,250,000 | $0 | - |
| Net PPE Purchase And Sale | $-154,460 | $0 | $0 | $-4,861 |
| Purchase Of PPE | $-154,460 | $0 | $0 | $-4,861 |
| Change In Working Capital | $3,018,202 | $2,056,439 | $-1,173,070 | $-7,570,996 |
| Change In Other Working Capital | $9,859,227 | $220,644 | $194,376 | - |
| Change In Other Current Liabilities | $82,195 | $0 | $0 | $0 |
| Change In Payables And Accrued Expense | $376,636 | $144,131 | $716,075 | $241,356 |
| Change In Payable | $376,636 | $144,131 | $716,075 | $241,356 |
| Change In Account Payable | $417,184 | $166,045 | $712,885 | $148,540 |
| Change In Tax Payable | $-40,548 | $-21,914 | $3,190 | $92,816 |
| Change In Income Tax Payable | $-40,548 | $-21,914 | $3,190 | $92,816 |
| Change In Prepaid Assets | $-6,440,314 | $-130,770 | $-95,151 | $-16,530 |
| Change In Inventory | $0 | $1,495,248 | $6,109,372 | $-7,795,822 |
| Change In Receivables | $-859,542 | $327,186 | $-8,097,742 | $0 |
| Other Non Cash Items | $-98,947 | $395,914 | - | - |
| Provisionand Write Offof Assets | $-100,000 | $7,369,797 | $8,274,526 | $0 |
| Asset Impairment Charge | $162,481,379 | $0 | $0 | $0 |
| Deferred Tax | $-30,804,128 | $0 | $0 | - |
| Deferred Income Tax | $-30,804,128 | $0 | $0 | - |
| Depreciation Amortization Depletion | $2,149,790 | $0 | $0 | $18,390 |
| Depreciation And Amortization | $2,149,790 | $0 | $0 | $18,390 |
| Depreciation | $2,149,790 | $0 | $0 | $18,390 |
| Net Income From Continuing Operations | $-135,469,133 | $-9,116,779 | $-13,084,038 | $-4,101,097 |
| Stock Based Compensation | - | $0 | $0 | $391,625 |
| Proceeds From Stock Option Exercised | - | - | $0 | $0 |
| Changes In Account Receivables | - | - | $-8,097,742 | $13,893 |
| Common Stock Payments | - | - | - | $0 |
| Net Long Term Debt Issuance | - | - | - | $-10,000,000 |
| Long Term Debt Payments | - | - | - | $-10,000,000 |
| Net Investment Purchase And Sale | - | - | - | $0 |
| Purchase Of Investment | - | - | - | $0 |
| Sale Of PPE | - | - | - | $0 |
| Interest Paid Cfo | - | - | - | $0 |
| Change In Other Current Assets | - | - | - | $0 |
| Change In Accrued Expense | - | - | - | $0 |
| Change In Interest Payable | - | - | - | $0 |
| Gain Loss On Sale Of PPE | - | - | - | $0 |
| Issuance Of Debt | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |